Avella Specialty Pharmacy, one of the nation’s largest and fastest growing independent specialty pharmacies, is proud to announce the addition of Rebecca M. Shanahan to its senior management team. Ms. Shanahan brings over two decades of highly successful leadership experience in the healthcare sector, as well as 5 years of service on Avella’s Board of Directors, to her new role as the Company’s Chief Executive Officer. John Musil, Pharm.D., FACA, the Company’s founder and CEO since inception, will continue to actively serve Avella as Chairman, focusing on long-term strategy and applying his unique combination of business expertise and pharmacist perspective as the Company’s ambassador to the clinical community.
Dr. Musil commented, “Avella has increased its revenue more than five-fold organically in the past five years and grown its operations correspondingly. To fully capitalize on the opportunities resulting from our success and scale, Avella is fortunate to have Rebecca Shanahan taking on the role of Chief Executive Officer. Not only does she bring a depth and breadth of healthcare, health plan, and specialty pharmacy expertise that will be instrumental to Avella’s ongoing growth, but she already has a strong understanding of our organization through her years of participation on the Board of Directors.”
Ms. Shanahan’s extensive healthcare experience broadly spans the provider sector. Earlier in her career, she served in executive roles at three highly regarded health systems, as Senior Vice President of Business Development for the University of Chicago Hospitals and Faculty Practice Plan, as Senior Vice President of Methodist Medical Group and Ambulatory Services, and as General Counsel of Community Hospitals of Indiana. From 1997 to 2005, Ms. Shanahan served as a Board Member, General Counsel, and EVP of Strategic Initiatives for Priority Healthcare. From 2005 to 2007, Ms. Shanahan served as Executive Vice President and Head of the Aetna Specialty Pharmacy. Since that time, she has provided consulting services to leading healthcare companies including Cardinal Health, Shoppers Drug Mart, Bayer Pharmaceuticals, Bristol Myers Squibb, Rite Aid, and Cancer Centers of Excellence.
“I am honored to be joining Avella at this exciting time,” Ms. Shanahan said. “The company has long been a leader and innovator in the development of unique specialty pharmacy services, with many well-deserved ‘best in class’ recognitions. I am excited about the opportunity to work with John, the Board of Directors, and the entire Avella team to continue to expand our clinical pharmacy, patient advocacy, and specialty pharmacy services into new disease categories and via new healthcare partnerships.”
Avella Specialty Pharmacy is a nationally accredited specialty pharmacy, providing compassionate and individualized care and support to patients since 1996. Avella's highly trained clinical pharmacists and staff members are experts in managing numerous complex disease states. The Company was founded in 1996 by John Musil as a single pharmacy in Phoenix, Arizona and has achieved exponential growth to become a unique specialty pharmacy platform with 4 centralized locations that fulfill specialty prescriptions and provide clinical support, together with 12 retail pharmacy locations. Under Dr. Musil’s leadership, Avella has appeared seven times on Inc. Magazine’s annual list fastest growing companies in the United States, has been recognized as a leading compounding pharmacy, and has earned URAC, PCAB, and VAWD accreditation. In 2011 Dr. Musil was named Entrepreneur of the Year among private companies at the Arizona Corporate Excellence awards. For more information about the Company, please visit www.avella.com.